In this Research Topic, we curated original and review articles that highlight the latest discoveries related to mechanisms of autophagy evasion by diverse pathogens, as well as the potential therapeutic targeting of autophagy pathways to enhance host defense and combat intracellular infections.
Mycobacterium tuberculosis evades host autophagy to promote intracellular survival. They also highlight the potential of selective autophagy enhancers as hostdirected therapies to complement existing antimicrobial treatments. If successfully translated into clinical practice, these approaches could improve treatment outcomes, particularly for drugresistant tuberculosis.Zhang et al. combine bioinformatic and experimental approaches to show that Brucella melitensis infection upregulates core autophagy genes, including ATG14, through the downregulation of miR-1, a negative regulator of ATG14, in sheep Leydig cells. These findings provide a mechanistic insight into the early host-pathogen interactions elicited by B. melitensis. Future work can reveal whether this regulatory axis alters autophagic flux and bacterial survival and determine its relevance to infection in vivo.Melanson et al. develop a dual-cell air-liquid interface (ALI) airway model incorporating differentiated epithelial cells and human peripheral blood monocyte-derived macrophages to investigate host-pathogen interactions during Pseudomonas aeruginosa infection. Macrophage incorporation into this model altered IL-8 secretion and bacterial spatial distribution without significantly affecting the overall bacterial burden. These findings highlight the importance of incorporating immune cells into airway models to better capture infection dynamics.Sundaram et al. review how type VII secretion systems contribute to Mycobacterium tuberculosis pathogenesis and immune evasion, including interference with phagosome maturation and autophagy. Further understanding how these systems manipulate host anti-bacterial pathways may reveal new therapeutic targets to enhance host defense against tuberculosis.
Mycobacterium tuberculosis disrupts host autophagy to evade immune clearance and persist within macrophages. They highlight the need for safer, more selective, hostdirected autophagy enhancers to complement current anti-bacterial therapies. They also emphasize the need to optimize the targeted delivery of autophagy activators and verify their efficacy and safety through systematic clinical studies.Li et al. review how poxviruses interact with host autophagy and the endo-lysosomal system, highlighting that these interactions vary across viral species and can either restrict or support infection. They also discuss how manipulating autophagy could help improve the effectiveness of oncolytic poxviruses for cancer therapy.Taken together, the contributions to this research topic highlight the complex and often opposing roles of autophagy in host defense and pathogen survival. From the manipulation of autophagic machinery by intracellular bacteria to the diverse interactions between viruses and host degradation pathways, these studies highlight the need to understand autophagy within the specific context of each infection. They also emphasize that successful therapeutic translation will require a clearer understanding of pathogen-specific mechanisms, cell-type-dependent responses, and the consequences of modulating autophagy in vivo. Ultimately, a deeper understanding of autophagy during infection may help bridge the gap between basic discoveries and the development of new treatments for infectious diseases.

